Z Rudolf
Impact in
- Biotechnology top 0.05%
- Microbial Inactivation Methods
- Transgenic Plants and Applications
- Immunology top 5%
- Toxin Mechanisms and Immunotoxins
Papers in
-
- Microbial Inactivation Methods 12
- Immunology 11
- Toxin Mechanisms and Immunotoxins 8
- Immunotherapy and Immune Responses 3
- Co-authors
- Gregor SeršaMaja ČemažarDamijan MiklavčičBorut ŠtabucMarko SnojLluis M. MirJulie GehlM. Marty
In The Last Decade
Z Rudolf
27 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Biotechnology 2.1k
- Immunology 842
- Physiology 157
- Biomedical Engineering 1.4k
- Oncology 276
Countries citing papers authored by Z Rudolf
This map shows the geographic impact of Z Rudolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z Rudolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z Rudolf more than expected).
Fields of papers citing papers by Z Rudolf
This network shows the impact of papers produced by Z Rudolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z Rudolf. The network helps show where Z Rudolf may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Z Rudolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 346 | |
| 2 | 2006 | 17 | |
| 3 | Genetic susceptibility to environmental carcinogenesis in Slovenian melanoma patients. | 2006 | 9 |
| 4 | 2005 | 50 | |
| 5 | Electrochemotherapy: advantages and drawbacks in treatment of cancer patients | 2003 | 69 |
| 6 | 2001 | 8 | |
| 7 | 2000 | 19 | |
| 8 | 2000 | 3 | |
| 9 | 2000 | 85 | |
| 10 | Electrochemotherapy with cisplatin: clinical experience in malignant melanoma patients. | 2000 | 156 |
| 11 | 1998 | 139 | |
| 12 | 1998 | 356 | |
| 13 | 1997 | 2 | |
| 14 | 1996 | 69 | |
| 15 | 1996 | 36 | |
| 16 | DTIC vs. IFN-alpha plus DTIC in the treatment of patients with metastatic malignant melanoma. | 1996 | 5 |
| 17 | 1995 | 20 | |
| 18 | THE FIRST CLINICAL EXPERIENCE IN MALIGNANT MELANOMA PA-TIENTS | 1995 | 8 |
| 19 | Electrochemotherapy with bleomycin. The first clinical experience in malignant melanoma patients | 1995 | 67 |
| 20 | Monocyte maturation index as a non specific tumor marker in cancer patients | 1985 | 1 |
About Z Rudolf
Z Rudolf is a scholar working on Biotechnology, Immunology, Immunology and Allergy, Cancer Research and Oncology, having authored 27 papers that have together received 2.6k indexed citations. Recurring topics across this work include Microbial Inactivation Methods (12 papers), Microfluidic and Bio-sensing Technologies (8 papers), Toxin Mechanisms and Immunotoxins (8 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Glutathione Transferases and Polymorphisms (3 papers), Immunotherapy and Immune Responses (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Biotechnology (2.1k citations), Immunology (842 citations), Physiology (157 citations), Biomedical Engineering (1.4k citations) and Oncology (276 citations). Z Rudolf has collaborated with scholars based in Slovenia, France and Denmark. Frequent co-authors include Gregor Serša, Maja Čemažar, Damijan Miklavčič, Borut Štabuc, Marko Snoj, Lluis M. Mir, Julie Gehl, M. Marty, V. Billard and Poul Geertsen. Their work appears in journals such as Melanoma Research, British Journal of Cancer, Pflügers Archiv - European Journal of Physiology, Oncology Reports and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.